Drug companies favor biotech meds over pills, citing new U.S. law
By Deena Beasley San Francisco (Reuters) – Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because recent U.S. legislation gives biologics a longer runway before becoming subject to government price limits, top industry executives said this week. The Inflation Reduction Act (IRA), which Democrats passed last August, for the …
Drug companies favor biotech meds over pills, citing new U.S. law Read More »